Lupin acquires Boehringer Ingelheim's brands Ondero and Ondero Met to expand diabetes portfolio in India
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Convergent action on AMR identified as an important area of intervention
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
Study efficacy measures will include the expression of dystrophin protein and motor function.
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Subscribe To Our Newsletter & Stay Updated